CIDRAP newsletters options
The Saudi Arabian Ministry of Health (MOH) released four new reports of MERS-CoV cases over the weekend, including two cases that had direct contact with camels.
On Mar 21, a 67-year-old Saudi man from Najran was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). He is in stable condition and had contact with camels.
A survey of 244 members of three infectious diseases societies reveals that the most common approached to antimicrobial stewardship programs (ASPs) are antibiotic reviews with prospective audit and feedback (PAF), prior authorization for select antibiotics, and guideline development, according to a study today in Clinical Infectious Diseases.
Illnesses from Salmonella Javiana, Thompson, and Infantis have risen about 50% in 10 years.
Nearly a third of hospitalized children get drugs to prevent, not treat, bacterial infections.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A 9-year single-center study by Columbia University scientists published yesterday in Infection Control & Hospital Epidemiology found that decreases in multidrug-resistant organisms (MDROs) were likely not due to implementing universal contact precautions (UCPs).
The rate of outpatient visits for influenza-like illnesses (ILI) dropped to 2.7% last week, close to the national baseline of 2.2%, according to the latest influenza surveillance data collected by the Centers for Disease Control and Prevention (CDC). This is the 17th week ILI has been at or above the national baseline.
The move is praised by some experts, but Redfield comes with a controversial past.
Resistance adds nearly $1,400 to the bill for treating a bacterial infection in the US.
The $1.3 trillion omnibus spending bill passed by the US House of Representatives today to fund the government through the end of September contains increases for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), according to official and media sources.
In a first for a Japanese company, CARB-X, a public-private collaboration that supports companies to combat antimicrobial resistance, has awarded Shionogi, of Osaka, $4.7 million to support the development of a novel beta-lactam antibiotic with potent activity against the worrisome superbugs that produce carbapenemase, including BL/BLI-resistant carbapenem-resistant Enterobacteriaceae (CRE), CARB-X said in a news release today.
Three of 13 patients have been hospitalized, and recalled products include those from Natural Grocers and International Harvest, Inc.
The vaccination campaign will aim to reach 78 million Brazilians by 2019.
Following an initial report of a case of measles at a daycare in Johnson County on Mar 8, the Kansas Department of Health and Environment (KDHE) said today that 10 cases in three counties have now been identified, including one not associated with the daycare center.
The British Society for Antimicrobial Chemotherapy (BSAC) today released a free e-book on global antimicrobial stewardship.
The CDC plans to post an announcement soon, which will include a recommendation that people not eat recalled Coconut Smiles Organic from Natural Grocers.
A new surveillance report from the European Centre for Disease Prevention and Control (ECDC) shows that the tuberculosis (TB) incidence rate in Europe is declining by an average of 4.3% a year, the fastest decline in the world compared with other regions. But officials warn that it's not falling fast enough to achieve the World Health Organization (WHO) goal of TB elimination in Europe by 2050.
Yesterday and today, the Saudi Arabian Ministry of Health (MOH) announced three new cases of MERS-CoV, including another household contact of a previously reported case in Jeddah.
Yesterday, the MOH said a 43-year-old Saudi man from Riyadh was in critical condition after being diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). The man had direct contact with camels.
New European avian flu detections include H5N6 in Sweden and Ireland, H5N8 in Italy, and low-path H5N3 in France.
Though many flu markers are declining, hospitalizations are still inching up, as expected in the latter part of the season.
